Analysis of prognostic factors and survival in patients with ovarian cancer treated with second-line hexamethylmelamine (altretamine).

Source:http://linkedlifedata.com/resource/pubmed/id/1904305

Download in:

View as

Triples

General Info

PMID
1904305